The latest medical news on Clinical Pharmacology

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about clinical pharmacology gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Pharma Forum

US govt claims access to first doses of Regeneron antibody cocktail REGN-COV2 for COVID-19 and Novavax vaccine candidate NVX‑CoV2373 via Operation ...

Pharma Forum

Professor Paul Kaye, whose research team was recently granted €8 million to help reduce the burden of leishmaniasis in African countries, takes us ...

Pharma Forum

The European Commission has approved AstraZeneca and MSD’s Lynparza (olaparib) in pancreatic cancer patients with a certain mutation. 

Pharma Forum

Advancing Sustainable, Streamlined API and Chemical Production using Enzyme Engineering & Scalable Biocatalytic Processes The development of enzyme...

Pharma Forum

Sanofi has gained exclusive worldwide rights to develop and market products from Dutch biotech Kiadis Pharma, in a deal worth up to 875 million eur...

Pharma Forum

External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace. Experts Andreas ...

Fierce Pharma

Roche has struck a deal with popular pharmacy and retailer Boots in a campaign to promote free access to its mySugr diabetes management app in the ...

Fierce Pharma

Welsh rugby player Gareth Thomas is speaking out against the stigma surrounding HIV, for himself and others, as the spokesman in an awareness campa...

Pharma Times

The drug is the only PARP inhibitor approved in this disease

Pharma Times

Phase I clinical testing scheduled to begin mid-July

Pharma Times

AGILE is a 'proof of confidence engine' designed to quickly identify the most promising compounds for treatment of COVID-19

Pharma Times

The long-acting, injectable therapy was 66% more effective than daily oral tablets at preventing HIV